Clinical Trials Browser

Phase 2 × Malignant Solid Tumor × Ramucirumab × Clear all

NCT01515306 2022-03-08

A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors

Phase 2 Completed

48 enrolled 17 charts

Other solid neoplasm

Malignant Solid Tumor

NCT01567163 2014-10-16

A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors

Phase 2 Completed

22 enrolled 15 charts

Other solid neoplasm

Malignant Solid Tumor